EGK AIPharmaCalc
AI Pharmacokinetics Calculator
$6.99 · In‑App Purchases · Designed for iPad. Not verified for macOS.
Edge AI pharmacokinetics on your iPhone/iPad. Simulate PK curves, get EGKAICore ADMET analysis, dose optimisation & drug comparison. Built for pharma & pharmacy students.
EGK AIPharmaCalc - Edge AI-Powered Pharmacokinetics Calculator
Master pharmacokinetics with the most advanced PK simulation and Edge AI interpretation tool for iPhone/iPad. Built by EGK Microelectronic Solutions Group, this app puts a full clinical pharmacokinetics engine in your pocket - designed for pharmacy students, pharmacologists, pharmaceutical scientists, and researchers.
SIMULATION ENGINE
Model plasma concentration-time curves using rigorous mathematical PK equations across four models: 1-Compartment, 2-Compartment, 3-Compartment, and Non-linear Michaelis-Menten. Simulate all routes of administration: oral (PO), IV bolus, IV infusion, intramuscular, subcutaneous, transdermal, and inhalation. Multiple-dose superposition with accumulation factor (R), steady-state Css, and trough/peak analysis.
KEY CALCULATED PARAMETERS
Every simulation computes Cmax, Tmax, t½, AUC₀₋t, AUC₀₋∞, MRT, observed CL, and Vd. Real-time derived parameters - half-life, elimination rate constant (Ke), and steady-state concentration - update instantly as you adjust sliders.
EGKAICore INTERPRETATION (PRO)
Let EGKAICore interpret your PK profile. Receive a full ADMET analysis (Absorption, Distribution, Metabolism, Excretion, Toxicity), toxicity risk classification (Low to Critical), clinical narrative, key findings, and dose adjustment recommendations for impaired renal or hepatic function.
PRO FEATURES
Therapeutic Window Analysis: Edge AI-estimated MEC (minimum effective concentration) and MTC (minimum toxic concentration) with visual window bar and percentage time in therapeutic range.
Edge AI Dose Optimisation: Set your target Cmin and Cmax - EGKAICore suggests an optimised dose and dosing interval to achieve your therapeutic goal.
Drug Comparison: Side-by-side PK overlay charts, comparative parameter table, and EGKAICore narrative comparing two drugs simultaneously.
SUBSCRIPTION INFORMATION
EGK AIPharmaCalc Pro is available as Monthly (RM 12.90/month) or Annual (RM 89.90/year) subscriptions. Payment is charged to your Apple ID account at purchase confirmation. Subscriptions automatically renew unless cancelled at least 24 hours before the end of the current period. Manage or cancel your subscription in App Store Settings. No cancellation of current subscription is allowed during the active period.
Privacy Policy: https://www.egkhor.com.my/privacy
Terms of Use: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
DISCLAIMER
For educational, research, and pharmaceutical training purposes only. Not for clinical decision-making or patient care. All results are computational models. Always consult a qualified pharmacist or physician.
EGK Microelectronic Solutions Group Sdn. Bhd.
sales@egkhor.com.my egkhor.com.my
Ratings & Reviews
- This app hasn’t received enough ratings or reviews to display an overview.
Fix UX bugs and minor bugs on optimise section
Introduce EGKAICore branding all views
The developer, Isaac Eng Gian Khor, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .
Data Not Collected
The developer does not collect any data from this app.
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
- Seller
- Isaac Eng Gian Khor
- Size
- 15.2 MB
- Category
- Medical
- Compatibility
Requires iOS 18.6 or later.
- iPhone
Requires iOS 18.6 or later. - iPad
Requires iPadOS 18.6 or later. - Mac
Requires macOS 15.6 or later and a Mac with Apple M1 chip or later. - Apple Vision
Requires visionOS 2.6 or later.
- iPhone
- Languages
- English
- Age Rating
4+
- 4+
- In-App Purchases
Yes
- aipharmacalc.pro.annual $19.99
- aipharmacalc.pro.monthly $2.99
- Copyright
- © EGK Microelectronic Solutions Group Sdn. Bhd. Isaac Khor
